Interestingly, similar associations between PYCARD variations and altered gene expression have been observed in various cancers, including lung cancer [22], breast cancer [23], schwannoma tumor [4], prostate cancer [24], and pancreatic ductal adenocarcinoma [10]. This evidence concerns the gene PYCARD and prostate carcinoma.